Overview

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

Status:
Unknown status

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the combination with ramipril and clopidogrel leads to further improvement of endothelial function, reduction of oxidative stress and reduction of vascular inflammation, compared with ramipril monotherapy, in patients with Diabetes Mellitus type 2 and diabetic nephropathy.

Phase:

Phase 4

Details

Lead Sponsor:

AHEPA University Hospital

Collaborator:

Aristotle University Of Thessaloniki

Treatments:

Clopidogrel
Ramipril
Ticlopidine